Die Mobiliar
Overview
Die Mobiliar is a Swiss insurance group that also operates as a corporate investor, making direct investments in startups and funding its venture capital subsidiary, Lightbird Ventures. It is also an anchor investor in the Swiss Entrepreneurs Fund.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SkyCell | Oct 2021 | Series C | Co-investor |
| Scope Group | Jan 2019 | Corporate Funding | Co-investor |
| Skribble | Sep 2022 | Series A | Co-investor |
| Carvolution AG | Oct 2022 | Series D | Lead |
| Nexxiot | Jan 2019 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Gina Domanig
Board Director
Andreas Gruetter
Chief Information Technology Architect
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Die Mobiliar based?
Die Mobiliar is headquartered in Bern, Switzerland.
When was Die Mobiliar founded?
Die Mobiliar was founded in 1826.
How many portfolio companies does Die Mobiliar have?
Die Mobiliar has 9 portfolio companies in Caplight's dataset.
What are some companies in Die Mobiliar's portfolio?
Portfolio companies visible on Caplight include SkyCell, Scope Group, Skribble, Carvolution AG, Nexxiot.
What was Die Mobiliar's most recent investment shown here?
Die Mobiliar's most recent investment in this portfolio sample was in Carvolution AG in 2022.
What sectors does Die Mobiliar focus on?
Die Mobiliar focuses on Mobility, Transportation & Logistics, FinTech, FinTech, FinTech, Mobility, Transportation & Logistics, Real Estate & PropTech, Enterprise Software, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Real Estate & PropTech, FinTech, Enterprise Software, Enterprise Software, Consumer & Commerce.
What company stages does Die Mobiliar focus on?
Die Mobiliar typically invests at the MultiStage stage.
What is Die Mobiliar's AUM?
Die Mobiliar's assets under management are estimated between $10.0B and $100.0B.